CONCEPT OF 505 (b) (2) APPLICATION: BENEFITS AND CHALLENGES

Journal Title: International Journal of Drug Regulatory Affairs - Year 2014, Vol 2, Issue 2

Abstract

A 505(b) (2) application is a new drug application (NDA) delineated in section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act.505(b)(2) application is one that one or a lot of the investigations relied upon by the applicant for approval "were not conducted by or for the applicant and has not obtained a right of reference or use from the person by or for whom the investigations were conducted. Section 505(b) (2) was added to FFDC Act by the Drug price competition and Patent Term Restoration Act of 1984 (Hatch-Waxman Amendments). The applicant will depend on either revealed literature or agency’s findings of an antecedent approved drug. This approval route was designed to encourage innovation and to eliminate expensive and long duplicative clinical studies.

Authors and Affiliations

Chaitanya Prasad K, Prabodh M, Ashish S,, Suthakaran R

Keywords

Related Articles

UNDERSTANDING TECHNICAL BARRIERS TO TRADE AGREEMENT

Signing of formation of World Trade Organization has transformed trade, services and intellectual property into a mutual, predictable exchange of trade and intellectual property protection among member countries. Countri...

REGULATORY ENVIRONMENT FOR MEDICAL DEVICES IN NEW ZEALAND

Medical Devices are one of the most important health intervention tools available for the prevention, diagnosis and treatment of diseases and for patient rehabilitation. Although the Medical Devices market in the New Zea...

QUALITY STANDARDS FOR MEDICAL DEVICES

Formerly with more augmented disabilities, Medical devices have become decisive device in many circumstances. As these are more perilous, the manufacturer should endow with an ideal medical device in aspects of safety &...

TECHNOLOGY DVELOPMENT FOR POLYMER MODIFICATION TO ENHANCE SOLUBILITY OF POORLY SOLUBLE DRUG

Solubilization of poorly soluble drugs is a frequently encountered challenge in screening studies of new chemical entities as well as in formulation design and development. Solubility of some drugs is very less; these dr...

EMERGENCY USE AUTHORIZATION: AT ZERO HOUR

The Emergency Use Authorisation (EUA) authority plays a vital role in US FDA. They provide the authority/permission to use the unregistered products/registered product with unregistered route to treat the life threatenin...

Download PDF file
  • EP ID EP345412
  • DOI -
  • Views 137
  • Downloads 0

How To Cite

Chaitanya Prasad K, Prabodh M, Ashish S, , Suthakaran R (2014). CONCEPT OF 505 (b) (2) APPLICATION: BENEFITS AND CHALLENGES. International Journal of Drug Regulatory Affairs, 2(2), 16-20. https://europub.co.uk/articles/-A-345412